selegiline parkinson
Selected indexed studies
- Selegiline and Parkinson's disease. Protective and symptomatic considerations. (Drugs, 1990) [PMID:2112994]
- Safety of selegiline (deprenyl) in the treatment of Parkinson's disease. (Drug Saf, 1998) [PMID:9673855]
- Selegiline--an overview of its role in the treatment of Parkinson's disease. (Clin Investig, 1992) [PMID:1600360]
_Worker-drafted node — pending editorial review._
Connections
selegiline parkinson is a side effect of
Sources
- Selegiline and Parkinson's disease. Protective and symptomatic considerations. (1990) pubmed
- Safety of selegiline (deprenyl) in the treatment of Parkinson's disease. (1998) pubmed
- Selegiline--an overview of its role in the treatment of Parkinson's disease. (1992) pubmed
- Monoamine Oxidase-B Inhibitors for the Treatment of Parkinson's Disease: Past, Present, and Future. (2022) pubmed
- Selegiline in the treatment of Parkinson's disease. (1989) pubmed
- Selegiline in Parkinson's disease. (1995) pubmed
- Effect of selegiline on mortality in patients with Parkinson's disease: a meta-analysis. (1998) pubmed
- Selegiline and mortality in Parkinson's disease. (1996) pubmed
- Parkinson's disease. (1990) pubmed
- Selegiline in the treatment of Parkinson's disease. (1991) pubmed